SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Doug Bean who wrote (1117)4/14/1999 12:34:00 PM
From: Benchman  Read Replies (2) of 1837
 
Saw this post on Yahoo:

--------------------------------------------------------------------
Breast Cancer Patients

I am a breast cancer survivor who was immediately taken off HRT [premarin] when I was diagnosed 18 months ago because of the estrogen sensitivity of my cancer[which is the most common type].While I am
prone to osteoporosis as well as heart disease, both of which are ameliorated by premarin, there has been no serious substitute for premarin until the vegetable based Cenestin came out. For persons like myself [and there are millions of breast cancer survivors and there will be millions more in the next two years], Cenestin is much more than a replacement for premarin---it is the 'only' drug that is viable to date. In other words, the real potential market for Cenestin is BREAST CANCER SURVIVORS. At least that is the way I see it.
---------------------------------------------------------------------

I also saw a post from a Cincinnati resident, that said the town is all a buzz on what's coming down the pike, and that they saw in the classifieds that Cardinal Health is looking for more sales people.

Rob
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext